Skip to content 
A key objective of the MX-Innovation consortium is to explore the use of MXenes as advanced cell-labeling tools to support biomedical applications, including early cancer diagnostics, improved transplant monitoring, and tissue regeneration. The team will investigate MXenes in Cytometry by Time of Flight (CyTOF), a mass spectrometry–based technique that employs metal tags to track cellular activity and analyze molecular interactions.
“Within this framework, we will apply our MXene-based tags to study extracellular vesicles — small particles that can act as models for cell membranes and may themselves serve as therapeutic carriers,” explained Dr. L. Delogu.
This effort is expected to expand the availability of MXenes for both commercial and academic research.
“By implementing innovative and economical methods for MXene synthesis and processing, we can broaden access to these materials while producing MXene-based products optimized for targeted applications in environmental protection and healthcare,” noted Dr. Oleksiy Gogotsi, CEO of Carbon-Ukraine. He will work alongside his brother, Drexel University professor Dr. Yury Gogotsi, on the project.
The MX-Innovation project is supported by the Khalifa University Research & Innovation Center for Graphene and 2D Materials (RIC2D) as part of its mission to transform two-dimensional materials into scalable solutions for global challenges in water, energy, medicine, and technology.